• 1. Emerging themes in soft matter: responsive and active soft materials
  Julia M. Yeomans Soft Matter, 2010,6, 703-704
• 2. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 3. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 4. Fe3O4@SiO2 core–shell nanoparticles for biomedical purposes: adverse effects on blood cells?
  C. Achilli,G. F. Guidetti,A. Ciana,D. Capsoni,G. Minetti Biomater. Sci., 2016,4, 1417-1421
• 5. Excited state characterization of carbonyl containing carotenoids: a comparison between single and multireference descriptions?
  Riccardo Spezia,Stefan Knecht,Benedetta Mennucci Phys. Chem. Chem. Phys., 2017,19, 17156-17166

Professional Introduction to Boc-lys(2-picolinoyl)-OH and CAS No 122532-80-3

Boc-lys(2-picolinoyl)-OH is a specialized chemical compound widely utilized in the field of pharmaceutical research and synthesis. This compound, identified by the CAS number CAS NO122532-80-3, plays a crucial role in the development of various bioactive molecules. The name itself provides significant insight into its chemical structure and functionality, highlighting its utility in peptide synthesis and modification.

The compound consists of a protected lysine residue, where the amino group is specifically modified with a Boc (tert-butoxycarbonyl) group, enhancing stability during synthetic processes. Additionally, the side chain of lysine is acylated with a 2-picolinoyl moiety, which imparts unique properties that make it valuable in medicinal chemistry applications. The 2-picolinoyl group, derived from picolinic acid, introduces a nitrogen-containing heterocycle that can influence the electronic and steric environment of the molecule.

In recent years, there has been growing interest in the development of novel peptidomimetics and modified peptides for therapeutic purposes. Boc-lys(2-picolinoyl)-OH has emerged as a key intermediate in these endeavors due to its ability to enhance peptide stability and bioavailability. The Boc protection ensures that the amino group remains unreactive under harsh conditions, allowing for selective modifications at other positions. This property is particularly advantageous in multi-step synthetic routes where orthogonal reactions are required.

One of the most compelling applications of Boc-lys(2-picolinoyl)-OH is in the field of protease inhibition. Proteases are enzymes that play critical roles in various biological pathways, making them attractive targets for drug development. By incorporating this modified lysine residue into peptide sequences, researchers can design inhibitors that exhibit enhanced binding affinity and selectivity. For instance, studies have demonstrated that peptides containing Boc-lys(2-picolinoyl)-OH can effectively inhibit certain proteases by forming stable interactions with their active sites.

The 2-picolinoyl group also contributes to the overall functionality of the compound by influencing its solubility and metabolic stability. Picolinic acid derivatives are known for their ability to interact with biological targets through hydrogen bonding and hydrophobic interactions. This makes Boc-lys(2-picolinoyl)-OH a versatile building block for designing molecules that can modulate biological processes with high precision.

Recent advancements in computational chemistry have further enhanced the utility of Boc-lys(2-picolinoyl)-OH in drug discovery. Molecular modeling studies have revealed that this compound can be integrated into complex molecular frameworks to create novel therapeutic agents. By leveraging computational tools, researchers can predict the binding modes and interactions of Boc-lys(2-picolinoyl)-OH with target proteins, facilitating the design of more effective drugs.

Moreover, the synthesis of Boc-lys(2-picolinoyl)-OH has been optimized to ensure high yield and purity, making it readily available for industrial applications. Modern synthetic methodologies allow for scalable production, enabling pharmaceutical companies to incorporate this compound into their drug development pipelines efficiently. The robustness of its synthetic route also ensures consistency in quality, which is paramount for clinical applications.

The role of Boc-lys(2-picolinoyl)-OH extends beyond protease inhibition; it has also been explored in the development of vaccines and immunomodulators. Peptides modified with this residue have shown promise in eliciting specific immune responses, making them valuable candidates for vaccine design. The ability to fine-tune peptide properties through structural modifications allows for the creation of vaccines with enhanced efficacy and safety profiles.

In conclusion, Boc-lys(2-picolinoyl)-OH (CAS NO122532-80-3) is a multifaceted compound with significant implications in pharmaceutical research and drug development. Its unique chemical structure and functional properties make it an indispensable tool for designing bioactive molecules with therapeutic potential. As research continues to uncover new applications for this compound, its importance in medicinal chemistry is set to grow further.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)